Nexium Dosage for Dogs Calculator
Evidence-based esomeprazole (Nexium) dosing for dogs — covering gastric ulcers, GERD, and acid-suppression protocols with capsule breakdown guidance.
Veterinary supervision required. Chronic PPI use can alter gut microbiome and reduce vitamin B12 absorption. Confirm indication before long-term use.
What Is Esomeprazole (Nexium)?
Esomeprazole is the S-enantiomer of omeprazole, a proton pump inhibitor (PPI) that irreversibly blocks the H⁺/K⁺-ATPase pump in gastric parietal cells, producing profound acid suppression. It is used in dogs for gastric ulcers, esophagitis, gastroesophageal reflux (GERD), Helicobacter-associated gastritis, and to protect the gastric mucosa during NSAID therapy.
PPIs require an acidic environment to be activated; they are pro-drugs converted to active sulfenamide in the secretory canaliculus. Onset of maximal effect is 3–5 days with repeated dosing. Available as 20 mg and 40 mg delayed-release capsules and IV powder for reconstitution.
Pharmacokinetics in Dogs
- Bioavailability: ~60–70% oral (food reduces absorption — give 30 min before meals)
- Onset: Single dose partial effect; full suppression after 3–5 days
- Half-life: ~1–2 hours (effect outlasts plasma half-life due to irreversible pump binding)
- Metabolism: Hepatic CYP2C19, CYP3A4
- Forms: 20 mg, 40 mg delayed-release capsules; IV 20 mg, 40 mg vials
How to Use This Calculator
- Enter your dog’s weight in kg or lbs
- Select the clinical indication
- Choose available capsule strength
- Click Calculate to see daily dose and tablet count
- Give capsules whole on an empty stomach, 30 minutes before first meal
🧮 Esomeprazole Dose Calculator
Esomeprazole Dosing Result
References
- Plumb DC. Plumb’s Veterinary Drug Handbook, 9th ed. Wiley-Blackwell; 2018.
- Marks SL, et al. ACVIM consensus statement on gastroprotectant use. J Vet Intern Med. 2018;32(6):1823-1840.
- Tolbert K, et al. Efficacy of oral famotidine and 2 omeprazole formulations for the control of intragastric pH in dogs. J Vet Intern Med. 2011;25(1):47-54.
